Barclays has downgraded Texas Instruments to "Underweight" from "Equal Weight," reducing its price target to $125 due to escalating U.S.-China trade tensions, rising production costs, and declining demand in key markets. The firm highlighted a significant risk from Texas Instruments' 20% exposure to China, where local semiconductor initiatives are eroding U.S. market share. With expectations of underutilization and margin pressure, Barclays forecasts a potential $1.00 reduction in 2026 earnings, projecting them at $6.49, or $5.50 in a downside scenario.